ICF (NASDAQ:ICFI), a global consulting and digital services provider, was awarded a re-compete contract by the U.S. Agency for International Development (USAID) to continue to implement its Demographic and Health Surveys Program (DHS). The contract, which was awarded by the Bureau for Global Health, has a contract value of over $200 million and a term of five years.
“Long recognized as a gold standard of survey research, the DHS Program provides vital information and builds in-country analytical capacity to help advance global understanding of health and population trends in lower and middle income countries,” said Leo Ryan, senior vice president for ICF. “We are thrilled to continue to support this important data collection, capacity building and data use program whose ultimate goal is to improve the overall health and economic status of populations in developing countries.”
ICF is expected to
ICF is also expected to help strengthen capacity of in-country institutions to enable them to collect and use data for their own decision-making purposes.
ICF (NASDAQ:ICFI) is a global consulting services company with over 7,000 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com.
Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and the effects of the novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on the health of our staff and that of our clients, the continuity of our and our clients' operations, our results of operations and our outlook. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements THAT are included in the "Risk Factors" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future.
Third Quarter Highlights
- Total Revenue Was $333 Million, Up 9 Percent
- Diluted EPS of $0.86, Inclusive of $0.05 of Special Charges1; Was $1.01, up 22 Percent
- Adjusted EBITDA1 Margin on Service Revenue1; Was 13.8 Percent
- Record Contract Awards of $647 Million up 61 Percent Y-o-Y; Trailing Twelve Month Contract Awards were $1.85 Billion, Representing a Book-to-Bill Ratio of 1.45